{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:32:44Z","timestamp":1774549964268,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.09.063","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T23:38:13Z","timestamp":1476661093000},"page":"5768-5776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague"],"prefix":"10.1016","volume":"34","author":[{"given":"Paul M.","family":"Arnaboldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya","family":"Sambir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"D\u2019Arco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos F.M.L.","family":"Seegers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond J.","family":"Dattwyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9568","key":"10.1016\/j.vaccine.2016.09.063_b0005","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"Prentice","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2016.09.063_b0010","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1016\/j.vaccine.2009.07.068","article-title":"Plague","volume":"27","author":"Williamson","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.09.063_b0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4269\/ajtmh.13-0191","article-title":"Plague gives surprises in the first decade of the 21st century in the United States and worldwide","volume":"89","author":"Butler","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2016.09.063_b0020","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.00306-06","article-title":"Resistance of Yersinia pestis to antimicrobial agents","volume":"50","author":"Galimand","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2016.09.063_b0025","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1371\/journal.pone.0000309","article-title":"Multiple antimicrobial resistance in plague: an emerging public health risk","volume":"2","author":"Welch","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.09.063_b0030","series-title":"Biohazard: the chilling true story of the largest covert biological weapons program in the world-told from inside by the man who ran it","author":"Alibek","year":"1999"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2016.09.063_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12044","article-title":"Protecting against plague: towards a next-generation vaccine","volume":"172","author":"Williamson","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2016.09.063_b0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcimb.2013.00004","article-title":"Regulation of the Yersinia type III secretion system: traffic control","volume":"3","author":"Dewoody","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.09.063_b0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.chom.2008.09.004","article-title":"Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis","volume":"4","author":"Depaolo","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.vaccine.2016.09.063_b0055","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/IAI.00105-08","article-title":"Yersinia pestis caf1 variants and the limits of plague vaccine protection","volume":"76","author":"Quenee","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.063_b0060","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3389\/fmicb.2015.01407","article-title":"Recombinant bivalent fusion protein rVE induces CD4+ and CD8+ T-cell mediated memory immune response for protection against Yersinia enterocolitica infection","volume":"6","author":"Singh","year":"2015","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.09.063_b0065","doi-asserted-by":"crossref","first-page":"e1004142","DOI":"10.1371\/journal.ppat.1004142","article-title":"TNFalpha and IFNgamma but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection","volume":"10","author":"Szaba","year":"2014","journal-title":"PLoS Pathog"},{"issue":"39","key":"10.1016\/j.vaccine.2016.09.063_b0070","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1016\/j.vaccine.2014.07.015","article-title":"Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant","volume":"32","author":"Dinc","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2016.09.063_b0080","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.063_b0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"issue":"41","key":"10.1016\/j.vaccine.2016.09.063_b0090","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1016\/j.vaccine.2010.07.084","article-title":"Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis","volume":"28","author":"del Rio","year":"2010","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2016.09.063_b0095","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1016\/j.vaccine.2010.06.070","article-title":"Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA","volume":"28","author":"Torres-Escobar","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.vaccine.2010.10.033","article-title":"Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge","volume":"29","author":"Branger","year":"2010","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2016.09.063_b0105","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.vaccine.2014.04.051","article-title":"Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo","volume":"32","author":"Kemnade","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.09.063_b0110","doi-asserted-by":"crossref","first-page":"e0130858","DOI":"10.1371\/journal.pone.0130858","article-title":"Development of a multivalent subunit vaccine against tularemia using tobacco mosaic virus (TMV) based delivery system","volume":"10","author":"Banik","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2016.09.063_b0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4161\/hv.27567","article-title":"Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge","volume":"10","author":"Mallajosyula","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0120","first-page":"6","article-title":"A single dose TMV-HA vaccine protects mice from H5N1 Influenza challenge","volume":"1","author":"Mallajosyula","year":"2016","journal-title":"Int J Vaccine Res"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.virol.2005.12.039","article-title":"Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications","volume":"348","author":"Smith","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2016.09.063_b0130","doi-asserted-by":"crossref","first-page":"e11199","DOI":"10.1371\/journal.pone.0011199","article-title":"Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen","volume":"5","author":"del Rio","year":"2010","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2016.09.063_b0135","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/17425247.2014.931936","article-title":"Intranasal formulations: promising strategy to deliver vaccines","volume":"11","author":"Riese","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.vaccine.2016.09.063_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.09.063_b0145","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.063_b0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/978-0-387-72124-8_35","article-title":"Cell-mediated defense against Yersinia pestis infection","volume":"603","author":"Smiley","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.09.063_b0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNFalpha and IFNgamma contribute to F1\/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"Lin","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630901X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630901X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T11:50:02Z","timestamp":1536321002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630901X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X1630901X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}